Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.

@article{Haim2001AcquiredAP,
  title={Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.},
  author={Nissim Haim and Naomi Lanir and Richard D. Hoffman and Alon Haim and Medy Tsalik and Benjamin Brenner},
  journal={The American journal of medicine},
  year={2001},
  volume={110 2},
  pages={91-6}
}
PURPOSE Cancer patients have an increased risk for venous thromboembolism. Because activated protein C resistance is a common risk factor for venous thromboembolism, we prospectively evaluated the activated protein C sensitivity ratio and factor V Leiden mutation in cancer patients with and without venous thromboembolism. SUBJECTS AND METHODS We studied 55 consecutive cancer patients with deep vein thrombosis, 58 cancer patients with no history of venous thromboembolism, 54 patients with… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
We studied 55 consecutive cancer patients with deep vein thrombosis , 58 cancer patients with no history of venous thromboembolism , 54 patients with venous thromboembolism without malignancy , and 56 healthy controls .
We studied 55 consecutive cancer patients with deep vein thrombosis , 58 cancer patients with no history of venous thromboembolism , 54 patients with venous thromboembolism without malignancy , and 56 healthy controls .
We studied 55 consecutive cancer patients with deep vein thrombosis , 58 cancer patients with no history of venous thromboembolism , 54 patients with venous thromboembolism without malignancy , and 56 healthy controls .
We studied 55 consecutive cancer patients with deep vein thrombosis , 58 cancer patients with no history of venous thromboembolism , 54 patients with venous thromboembolism without malignancy , and 56 healthy controls .
All Topics